Delivery Order SPE2DB24D2212-SPE2DB25FHNYB

Award Date 2/6/25
Potential Completion Date 2/7/25
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,770.94 firm fixed-price delivery order contract is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of May 31, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a $5,011.33 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the supply of CONTRAVE ER 8-90 MG TABLET 120S medication to support military healthcare programs. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, worth $1,326.04, is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 14, 2023. There is no set-aside designation for this contract. AmerisourceBergen...
This federal contract award is for $16,532.32 and was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract does not have a...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,953.95 Firm Fixed Price Delivery Order contract is for the provision of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of November 3, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,419.87 firm fixed-price delivery order is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a specialty medication, to support military healthcare programs. The contract has an ultimate completion date of November 22, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,685.63 firm fixed-price delivery order is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a medication. The contract has an ultimate completion date of January 17, 2024 and is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,179.69 firm fixed price delivery order is for the drug product CONTRAVE ER 8-90 MG TABLET 120S, with a completion date of December 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to deliver Contrave ER 8-90 mg tablets. The $4,090.31 firm fixed-price delivery order has an ultimate completion date of October 26, 2023 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a...
This federal contract award, valued at $28,847.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of CONTRAVE ER 8-90 MG TABLET 120S. The contract is a Firm Fixed Price Delivery Order with a period of performance through May 31, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
  • SPE2DB24D2212
    Indefinite Delivery Contract
  • SPE2DB24D2212-SPE2DB25FHNYB
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,765.89 firm fixed-price delivery order contract is for CONTRAVE ER 8-90 MG TABLET 120S, a cardiovascular medication. The contract has an ultimate completion date of February 7, 2025.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award did not have a set-aside designation, indicating open competition.

Generated 5/8/25, 9:48 AM